W

Whanin Pharm Co Ltd
KRX:016580

Watchlist Manager
Whanin Pharm Co Ltd
KRX:016580
Watchlist
Price: 11 570 KRW -0.6% Market Closed
Market Cap: 176.6B KRW

Whanin Pharm Co Ltd
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Whanin Pharm Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
W
Whanin Pharm Co Ltd
KRX:016580
Income from Continuing Operations
â‚©16.4B
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
Yuhan Corp
KRX:000100
Income from Continuing Operations
â‚©66.4B
CAGR 3-Years
-11%
CAGR 5-Years
-17%
CAGR 10-Years
-4%
SK Biopharmaceuticals Co Ltd
KRX:326030
Income from Continuing Operations
â‚©241.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Income from Continuing Operations
â‚©117.8B
CAGR 3-Years
6%
CAGR 5-Years
22%
CAGR 10-Years
10%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Income from Continuing Operations
-â‚©9.6B
CAGR 3-Years
-99%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Income from Continuing Operations
â‚©30B
CAGR 3-Years
5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Whanin Pharm Co Ltd
Glance View

Market Cap
176.6B KRW
Industry
Pharmaceuticals

Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. The company is headquartered in Seoul, Seoul. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company’s products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The firm also involves in the real estate rental business.

Intrinsic Value
7 586.53 KRW
Overvaluation 34%
Intrinsic Value
Price
W

See Also

What is Whanin Pharm Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
16.4B KRW

Based on the financial report for Jun 30, 2025, Whanin Pharm Co Ltd's Income from Continuing Operations amounts to 16.4B KRW.

What is Whanin Pharm Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-1%

Over the last year, the Income from Continuing Operations growth was -44%. The average annual Income from Continuing Operations growth rates for Whanin Pharm Co Ltd have been -11% over the past three years , -3% over the past five years , and -1% over the past ten years .

Back to Top